Business
Director/PDMR Shareholding
AstraZeneca PLC has announced a transaction by Nazneen Rahman, a Non-Executive Director, who sold 297 ordinary shares at a price of £134.96 per share on 18 December 2025. This notification was made in accordance with EU Market Abuse Regulation requirements. Disclaimer*
About this update from Astrazeneca Plc
[{"type":"text","content":"\n\n22 December 2025\n \nTransaction by Person Discharging Managerial Responsibilities\n \nAstraZeneca PLC (the Company) announces that, on 18 December 2025, it was notified of a transaction in the Company's ordinary shares of $0.25 each (Ordinary Shares), by Nazneen Rahman, Non-Executive Director, on 18 December 2025, as set out below.\n \n \n\n\n\n\nPDMR \n\n\nPosition \n\n\nNature of the transaction \n\n\nQuantity \n\n\nPrice per Ordinary Share\n\n\n\n\nNazneen Rahman\n\n\nNon-Executive Director\n\n\nSale of Ordinary Shares \n\n\n297\n\n\n£134.96\n\n\n\n\n \n \nFurther details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018.\n \n \n\n\n\n\n1\n \n\n\nDetails of the person discharging managerial responsibilities / person closely associated\n\n\n\n\na)\n \n\n\nName\n\n\nNazneen Rahman\n\n\n\n\n2\n \n\n\nReason for the notification\n \n\n\n\n\na)\n \n\n\nPosition/status\n \n\n\nNon-Executive Director\n\n\n\n\nb)\n \n\n\nInitial notification/Amendment\n\n\nInitial notification\n\n\n\n\n3\n \n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\na)\n \n\n\nName\n\n\nAstraZeneca PLC\n\n\n\n\nb)\n \n\n\nLEI\n\n\nPY6ZZQWO2IZFZC3IOL08\n\n\n\n\n4i\n \n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)\n \n\n\nDescription of the financial instrument, type of instrument\n \nIdentification code\n\n\nOrdinary Shares of US$0.25 each in AstraZeneca PLC\n \nGB0009895292\n \n\n\n\n\nb)\n \n\n\nNature of the transaction\n \n \n\n\nSale of Ordinary Shares of US$0.25 each in AstraZeneca PLC\n \n\n\n\n\nc)\n \n\n\nPrice(s) and volume(s)\n \n\n\n \n\n\n\n\nPrice(s)\n\n\nVolume(s)\n\n\n\n\n£134.96\n\n\n297\n\n\n\n\n\n\n\n\n\nd)\n \n\n\nAggregated information\n \n- Aggregated volume\n- Price\n\n\nNot applicable - single transaction\n \n \n \n \n\n\n\n\ne)\n \n\n\nDate of the...